Neurobiological Technologies Price on December 16, 2024

NTIIDelisted Stock  USD 0.0001  0.00  0.00%   
If you're considering investing in Neurobiological Stock, it is important to understand the factors that can impact its price. As of today, the current price of Neurobiological Technologies stands at 0.0001, as last reported on the 16th of December 2024, with the highest price reaching 0.0001 and the lowest price hitting 0.0001 during the day. We have found three technical indicators for Neurobiological Technologies, which you can use to evaluate the volatility of the firm.
  
Neurobiological Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
NTII
Based on monthly moving average Neurobiological Technologies is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Neurobiological Technologies by adding Neurobiological Technologies to a well-diversified portfolio.

Neurobiological Technologies Valuation on December 16, 2024

It is possible to determine the worth of Neurobiological Technologies on a given historical date. On December 16, 2024 Neurobiological was worth 1.0E-4 at the beginning of the trading date compared to the closed value of 1.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Neurobiological Technologies stock. Still, in general, we apply an absolute valuation method to find Neurobiological Technologies' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Neurobiological Technologies where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Neurobiological Technologies' related companies.
 Open High Low Close Volume
12/16/2024
  0.0001    0.0001    0.0001    0.0001    0.00  
Backtest Neurobiological Technologies  |  Neurobiological Technologies History  |  Neurobiological Technologies Valuation 
Open Value
1.0E-4
1.0E-4
Closing Value
0.00
Upside

Neurobiological Technologies Trading Date Momentum on December 16, 2024

Neurobiological Technologies Fundamentals Correlations and Trends

By evaluating Neurobiological Technologies' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Neurobiological Technologies' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Neurobiological financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Neurobiological Technologies Stock history

Neurobiological Technologies investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Neurobiological is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Neurobiological Technologies will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Neurobiological Technologies stock prices may prove useful in developing a viable investing in Neurobiological Technologies
Neurobiological Technologies, Inc. operates under a plan of liquidation and dissolution approved by stockholders in October 2009. The company was founded in 1987 and is based in Emeryville, California. Neurobiological Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.

Neurobiological Technologies Stock Technical Analysis

Neurobiological Technologies technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Neurobiological Technologies technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Neurobiological Technologies trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Neurobiological Technologies Period Price Range

Low
December 16, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Neurobiological Technologies cannot be verified against its exchange. Please verify the symbol is currently traded on OTCCE Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Neurobiological Technologies December 16, 2024 Market Strength

Market strength indicators help investors to evaluate how Neurobiological Technologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Neurobiological Technologies shares will generate the highest return on investment. By undertsting and applying Neurobiological Technologies stock market strength indicators, traders can identify Neurobiological Technologies entry and exit signals to maximize returns
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Consideration for investing in Neurobiological Stock

If you are still planning to invest in Neurobiological Technologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Neurobiological Technologies' history and understand the potential risks before investing.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Stocks Directory
Find actively traded stocks across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities